All Comments by Alexei Koudinov

  1. Toxicity of beta-amyloid vaccination in patients with Alzheimer's disease.
  2. Tau function and dysfunction in neurons: its role in neurodegenerative disorders.
  3. Therapeutic vaccines: realities of today and hopes for the future.
  4. Reversal of amyloid beta toxicity in Alzheimer's disease model Tg2576 by intraventricular antiamyloid beta antibody.
  5. Immunization delays the onset of prion disease in mice.
  6. Potential neurotoxic inflammatory responses to Abeta vaccination in humans.
  7. Cholesterol and Alzheimer's disease.
  8. A novel mechanism for the regulation of amyloid precursor protein metabolism.
  9. Generation of amyloid beta peptide with pyroglutamate at position 3 in primary cortical neurons.
  10. The Th1/E47cs-G apolipoprotein E (APOE) promoter allele is a risk factor for Alzheimer disease of very later onset.
  11. Physiopathological modulators of amyloid aggregation and novel pharmacological approaches in Alzheimer's disease.
  12. Evolution of beta-amyloid induced neuropathology: magnetic resonance imaging and anatomical comparisons in the rodent hippocampus.
  13. Profile of cholesterol-related sterols in aged amyloid precursor protein transgenic mouse brain.
  14. beta-Amyloid neurotoxicity is exacerbated during glycolysis inhibition and mitochondrial impairment in the rat hippocampus in vivo and in isolated nerve terminals: implications for Alzheimer's disease.
  15. Cholesterol metabolism in the brain.